Leading eye care services provider Dr. Agarwal’s Healthcare will launch its 3027.26 crore IPO(Initial Public Offering) on 29th January. The IPO is combined of fresh issue and offer for sale(OFS). According to Crisil report Dr. Agarwal’s Healthcare’s market share was approximately 25% of the total eye care service chain market in India During the financial year 2023-24.

The issue is a combination of fresh issue 0.75 crore shares aggregating to 300 crore and rest offer for sale of 6.78 crore shares aggregating to 2727.26 crore.

Dr. Agarwal’s Healthcare IPO will open on Wednesday 29 January 2025 and close on Friday 31 January 2025. The Allotment of this IPO is expected to be finalized on Monday, 3 February 2025 and Dr. Agarwal’s Healthcare IPO will on both exchanges BSE and NSE. The Tentative listing Date of this IPO is fixed on Wednesday, 5 February 2025.

 The price band of Dr. Agarwal’s IPO is set at Rs. 382 to Rs. 402 per equity share. The minimum lot size for an application is 35. The minimum investment required by a retail investor is 14,070 at the higher price band of this IPO. Minimum 15 lots(525 shares) aggregating to Rs. 2,11,050 is required to apply in the category of small NII and for the big NII, it is 72 lots(2520) required, amounting to Rs. 10,13,040 at the higher price band of Rs. 402.

Not more than 50% of total issue is reserved for Qualified Institutional Buyers(QIB), retail quota in this Dr. Agarwal’s IPO is not less than 35% of the total shares offered and not less than 15% is reserved for NII(HNI).

The promoters of Dr. Agarwal’s Healthcare company are Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr. Adil Agarwal, Dr. Anosh Agarwal, Dr. Ashvin Agarwal, Dr. Ashar Agarwal, Dr. Amar Agarwal family trust, Dr. Adil Agarwal family trust, Dr. Anish Agarwal family trust, Dr. Ashvin Agarwal family trust, Dr. Ashar Agarwal family trust, Dr. Agarwal’s Eye Institute and Dr. Agarwal’s eye Institute private limited.

Company Incorporated in 2010, Dr. Agarwal’s Health Care limited offers a comprehensive range of eye care services, including cataract and refractive surgeries consultations, diagnoses, non surgical treatments and sale of optical products, contact lenses, accessories and eye care related medicines and items.

As of 30 September 2024 in current financial year 2025 company’s revenue stood at 837.94 crore and profit after tax was 39.56 crore. Total Borrowing on the company was 373.68 crore.

In the Last financial year 2024 company’s revenue was 1376.45 crore and profit after tax(PAT) stood at 95.05 crore.

In The financial year 2023 company’s revenue stood at  1031.49 crore and profit after tax(PAT) crossed 100 crore mark and stood at 103.23 crore.

In the RHP of Dr. Agarwal’s Healthcare IPO, company financial is decent and shown the growth in the company’s financials.

Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Private Limited, Jefferies India Pvt. Ltd, Motilal Oswal Investment Advisors Limited are running lead managers of Dr. Agarwal’s Healthcare IPO and Kfin Technologies Limited is the registrar.

Total issue size of Dr. Agarwal’s Healthcare is 3027.26 crore but majority of issue is odd and only 300 crore will go into the company. By the fresh issue Company wants to reduce it’s borrowings and general corporate purposes.

 According Investorgain GMP(Grey Market Premium) of Dr. Agarwal’s Healthcare IPO is around 15% on 25 January, it is indicating a listing gain of 15% on 1 lot. It may change in upcoming days.

Disclaimer:- Here we are giving the information only about the company’s performance. You should take advice from your financial advisor before investing.